← FDA Drug Approvals (Drugs@FDA)

NYSTATIN AND TRIAMCINOLONE ACETONIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-03-04

Drug application

FDA Application #

ANDA214186

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN AND TRIAMCINOLONE ACETONIDE

Generic name

NYSTATIN AND TRIAMCINOLONE ACETONIDE

Active ingredients

NYSTATIN; TRIAMCINOLONE ACETONIDE

Dosage form

OINTMENT

Route

TOPICAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2022-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown